| Primary |
| Blood Potassium Decreased |
24.0% |
| Mineral Supplementation |
14.0% |
| Product Used For Unknown Indication |
10.0% |
| Diuretic Therapy |
6.0% |
| Arthritis |
4.0% |
| Blood Cholesterol Increased |
4.0% |
| Cardiac Disorder |
4.0% |
| Depression |
4.0% |
| Hypertension |
4.0% |
| Hypokalaemia |
4.0% |
| Urinary Incontinence |
4.0% |
| Blood Potassium |
2.0% |
| Blood Pressure Increased |
2.0% |
| Colitis |
2.0% |
| Diabetes Mellitus |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Electrolyte Substitution Therapy |
2.0% |
| Familial Periodic Paralysis |
2.0% |
| Fibromyalgia |
2.0% |
| Muscle Spasms |
2.0% |
|
| Fatigue |
10.3% |
| Medication Error |
10.3% |
| Medication Residue Present |
10.3% |
| Diarrhoea |
6.9% |
| Drug Interaction |
6.9% |
| Product Formulation Issue |
6.9% |
| Blood Magnesium Decreased |
3.4% |
| Colitis |
3.4% |
| Convulsion |
3.4% |
| Dizziness |
3.4% |
| Drug Ineffective |
3.4% |
| Flatulence |
3.4% |
| Malaise |
3.4% |
| Medication Residue |
3.4% |
| Melaena |
3.4% |
| Muscle Spasms |
3.4% |
| Nausea |
3.4% |
| Overdose |
3.4% |
| Pancreatitis |
3.4% |
| Product Physical Issue |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
29.2% |
| Drug Use For Unknown Indication |
10.3% |
| Blood Potassium Decreased |
6.1% |
| Blood Pressure |
6.1% |
| B-cell Lymphoma |
5.5% |
| Prostate Cancer |
4.6% |
| Foetal Exposure During Pregnancy |
4.3% |
| Depression |
4.0% |
| Arthritis |
3.3% |
| Blood Cholesterol Increased |
3.0% |
| Diabetes Mellitus |
3.0% |
| Fibromyalgia |
3.0% |
| Hypertension |
2.7% |
| Pain |
2.7% |
| Mineral Supplementation |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.1% |
| Pulmonary Arterial Hypertension |
2.1% |
| Gout |
1.8% |
| Ill-defined Disorder |
1.8% |
| Sleep Disorder |
1.8% |
|
| Renal Failure Acute |
11.5% |
| Urticaria |
9.6% |
| Blood Potassium Decreased |
5.8% |
| Dizziness |
5.8% |
| Drug Interaction |
5.8% |
| Hypertension |
5.8% |
| Medication Residue Present |
5.8% |
| Cerebrovascular Accident |
3.8% |
| Diabetes Mellitus |
3.8% |
| Gastric Ulcer Haemorrhage |
3.8% |
| Insomnia |
3.8% |
| Joint Swelling |
3.8% |
| Medication Residue |
3.8% |
| Myalgia |
3.8% |
| Nausea |
3.8% |
| Surgery |
3.8% |
| Swelling |
3.8% |
| Urine Arsenic Increased |
3.8% |
| Vision Blurred |
3.8% |
| Vomiting |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.7% |
| Drug Use For Unknown Indication |
15.5% |
| Hypertension |
9.8% |
| Pain |
4.7% |
| Blood Cholesterol Increased |
3.0% |
| Diabetes Mellitus |
3.0% |
| Depression |
3.0% |
| Atrial Fibrillation |
3.0% |
| Cardiac Disorder |
2.7% |
| Rheumatoid Arthritis |
2.4% |
| Osteoporosis |
2.3% |
| Multiple Myeloma |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Anxiety |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Pulmonary Arterial Hypertension |
2.0% |
| Asthma |
1.9% |
| Prophylaxis |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Arthritis |
1.7% |
|
| Weight Decreased |
12.3% |
| Vomiting |
12.0% |
| Weight Increased |
10.9% |
| Death |
8.3% |
| Pneumonia |
5.1% |
| Urinary Tract Infection |
5.0% |
| Drug Ineffective |
4.5% |
| Dyspnoea |
4.5% |
| Oedema Peripheral |
4.0% |
| Myocardial Infarction |
3.7% |
| Nausea |
3.6% |
| Rash |
3.4% |
| Pain |
3.3% |
| Tremor |
3.1% |
| Renal Failure Acute |
2.9% |
| Syncope |
2.9% |
| Vision Blurred |
2.7% |
| Pain In Extremity |
2.6% |
| Renal Failure |
2.6% |
| Wheezing |
2.5% |
|
| Interacting |
| Blood Pressure Abnormal |
26.7% |
| Mineral Supplementation |
16.7% |
| Blood Cholesterol Increased |
13.3% |
| Diabetes Mellitus |
13.3% |
| Product Used For Unknown Indication |
13.3% |
| Atrial Fibrillation |
3.3% |
| Blood Potassium Decreased |
3.3% |
| Hypertension |
3.3% |
| Hypertonic Bladder |
3.3% |
| Urinary Incontinence |
3.3% |
|
| Drug Interaction |
42.9% |
| Drug Ineffective |
28.6% |
| Medication Residue |
14.3% |
| Nausea |
14.3% |
|
